Renal effect of severe hypoxia evaluated By NGAL measurements: An in vivo and in vitro study.

NGAL Neutrophil gelatinase-associated lipocalin acute kidney injury hypobaric hypoxia ischemic preconditioning

Journal

Urologia
ISSN: 1724-6075
Titre abrégé: Urologia
Pays: United States
ID NLM: 0417372

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 21 4 2021
medline: 15 1 2022
entrez: 20 4 2021
Statut: ppublish

Résumé

To investigate possible renal damage in healthy men exposed to extreme hypobaric hypoxia, using urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration as biomarker. The value of NGAL as a biomarker of proximal tubular cell damage under hypoxic conditions was also tested in vitro experiments. NGAL was assayed in a cohort of air cadets ( In the in vivo study, geometric means of urinary NGAL/Cr ratio measured 24 h after hypobaric hypoxia in the hypobaric chamber were significantly lower than baseline values (13.4 vs 25.9 ng/mg, Exposure to hypobaric-hypoxic environments does not cause significant and irreversible renal tubular injury in vivo and in vitro, except than in a late stage. The hypoxic insult does not seem to be mirrored by an increase of urinary NGAL in healthy men nor of NGAL gene expression in HK-2 cell culture or secretion in the culture medium in the in vitro conditions reported in the present study.

Identifiants

pubmed: 33876675
doi: 10.1177/03915603211009117
doi:

Substances chimiques

Biomarkers 0
Lipocalin-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-43

Auteurs

Emilio Sacco (E)

Department of Urology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Matteo Vittori (M)

Department of Urology, San Carlo di Nancy Hospital, Rome, Italy.

Pietro Manuel Ferraro (PM)

Nephrology Department, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Paola Verde (P)

Italian Air Force, Flight Experimental Center, Aerospace Medicine Department, Pratica di Mare, Italy.

Alessandro Scagliusi (A)

Italian Air Force, Flight Experimental Center, Aerospace Medicine Department, Pratica di Mare, Italy.

Silvia Baroni (S)

Clinical Chemistry, Biochemistry and Molecular Biology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Valentina Masola (V)

Renal Unit, Department of Medicine, Integrated University Hospital of Verona, Verona, Veneto, Italy.

Maurizio Onisto (M)

Department of Biomedical Sciences, University of Padua, Padova, Veneto, Italy.

Maria Nicosia (M)

Clinical Chemistry, Biochemistry and Molecular Biology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

PierFrancesco Bassi (P)

Department of Urology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH